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Impact of abdominal fat and 
insulin resistance on arterial 
hypertension in non-obese women
Impacto da gordura abdominal e resistência à insulina 
na hipertensão arterial em mulheres não-obesas
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AbstrAct
Objective: To evaluate the impact of abdominal fat and insulin resistance on arterial hyperten-
sion of non-obese women. Methods: Thirty-five non-obese women (NO), age 35-68 years were 
studied, and divided into two groups according to the presence of hypertension (BP ≥ 140 x 
90 mmHg) ( HT = hypertensive; NT = normotensive). Leptin measurement and oral glucose tole-
rance test (OGTT) to assess insulin were performed in these patients. A CT-scan was used to eva-
luate visceral (VF) and subcutaneous abdominal fat (SCF). The Central fat distribution index (CDI) 
was proposed to evaluate the impact of subcutaneous abdominal fat on central fat distribution 
in hypertensive patients. Results: When compared to NT-NO (n = 17) group, HT-NO (n = 18) sho-
wed higher blood pressure levels (systolic and diastolic), greater VF area (84.40 ± 55.70 versus 
37.50 ± 23.00 cm²; p = 0.036), greater SCF area (174.30 ± 83.00 versus 79.80 ± 27.40 cm2; p = 0.030), 
higher HOMAr index (1.59 ± 0.72 versus 0.93 ± 0.48 mmol.mU/L2; p = 0.006), higher CDI index 
(12.67 ± 7.04 versus 6.19 ± 2.57 cm2/kg) and higher leptin level (19.1 ± 9.6 versus 7.4 ± 3.5 ng/mL; 
p = 0.028). Conclusions: Arterial hypertension in non-obese women is associated with insulin 
resistance, central fat distribution and higher leptin levels. Arq Bras Endocrinol Metab. 2009;53(3):340-3.
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resumo
Objetivo: Avaliar o impacto da gordura abdominal e resistência à insulina na hipertensão arte-
rial em mulheres não-obesas. Métodos: Foram estudadas 35 mulheres não obesas (NO), com 
idade entre 35 e 68 anos, separadas em dois grupos de acordo com a presença de hipertensão 
arterial (PA ≥ 140 x 90 mmHg) (HT = hipertenso; NT = normotenso). A leptina foi dosada e um 
OGTT realizado. Um corte tomográfico foi usado para avaliar a gordura visceral (VF) e sub-
cutânea abdominal (SCF). O índice de distribuição central de gordura (CDI) foi proposto para 
avaliar o impacto da gordura subcutânea abdominal na distribuição central de gordura em pa-
cientes hipertensas. Resultados: Quando comparado ao grupo NT-NO (n = 17), o grupo HT-NO 
(n = 18) mostrou maiores níveis de pressão arterial (sistólica e diastólica), maior área de gordu-
ra visceral (84.40 ± 55.70 versus 37.50 ± 23.00 cm2; p = 0.036), maior área de gordura subcutânea 
abdominal (174.30 ± 83.00 versus 79.80 ± 27.40 cm2; p = 0.030), maior HOMAr (1.59 ± 0.72 versus 
0.93 ± 0.48 mmol.mU/L2; p = 0.006), maior índice CDI (12.67 ± 7.04 versus 6.19 ± 2.57 cm2/kg) e 
maior nível de leptina (19.1 ± 9.6 versus 7.4 ± 3.5 ng/mL; p = 0.028). Conclusões: A hipertensão 
arterial em mulheres não obesas está associada à resistência à insulina, distribuição central de 
gordura e altos níveis de leptina. Arq Bras Endocrinol Metab. 2009;53(3):340-3.
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IntroDuctIon 
The relation between obesity and cardiovascular risk 
(1-4) has been widely demonstrated and is a common 
findings of metabolic syndrome (MS). Some studies 
have shown that arterial hypertension in MS is associ-
ated with insulin resistance and central fat distribution, 
increasing cardiovascular risk (5,6) which may be ex-
plained by the elevated lipolitic rate of visceral fat that 
increases free fatty acid (FFA) levels in portal circulation, 
leading to insulin resistance and hyperinsulinemia (3,4). 
The hyperinsulinemia may increase arterial blood pres-
sure by adrenergic or renal mechanisms (7-10).
Other studies have suggested that leptin may increase 
blood pressure (11-13) and hyperactivity of the renin-
angiotensin system (RAS) has also been reported (14).
Arterial hypertension in lean subjects may be associ-
ated with insulin resistance, mainly peripheral insulin 
resistance, with higher serum glucose and insulin levels 
being detected after OGTT.
The aim of this study was to evaluate the association 
of abdominal fat, insulin resistance and arterial hyper-
tension in non-obese women.
reseArch methoDs AnD proceDures
A cross-sectional study including 35 non-obese (NO) 
women, aging from 35 to 68 was performed from au-
gust 2001 to august 2003. Patients were divided into 
two groups according to the presence of arterial hy-
pertension (BP ≥ 140 x 90 mmHg) : NT-NO (normo-
tensive non-obese; n = 17) and HT-NO (hypertensive 
non-obese; n = 18). These patients were in treatment 
with antihypertensive medications discontinued thera-
py for at least seven days prior to the study. Obesity was 
defined as body mass index (BMI) ≥ 30 kg/m². Hyper-
tension was defined as either systolic or diastolic office 
blood pressures ≥ 140 x 90 mmHg. 
Exclusion criteria were self-reported diabetes and/or 
the taking of antihypertensive medications, cardiac, renal 
or hepatic diseases and secondary arterial hypertension.
The same observer has measured weight, height, 
waist and hip circumferences. BMI was calculated as 
weight (kilograms) divided by height (meters) squared. 
Office blood pressure was based on the average of 
two seated readings after five minutes of rest. After a 
12-hour fasting period, serum glucose level (glucose 
oxidase) was determined at 0, 30, 60, 90 and 120 min-
utes after a 75g oral glucose load. Serum insulin (Auto 
Delfa, Perkin Elmer) was determined at 0 and 120 min-
utes of OGTT. Leptin levels (Elisa, Linco Research, 
USA) were measured.
Visceral and subcutaneous fat areas (density -50 to 
-250 HU) were obtained by a computed tomography 
(Picker International) in a single tomographic slice, at 
the L4-L5 level, expressed in cm2.
Homeostasis model for assessment of insulin resistance 
index (HOMAr index) was calculated using the formula: 
fasting glucose x fasting insulin / 22.5 (mmol.mU/L2). 
The insulin secretion index (HOMA beta) was cal-
culated using the formula: 20 x fasting insulin/fasting 
glucose – 3.5 (%). Insulin sensitivity index (ISI), pro-
posed by Belfore and cols. (15), was calculated.
We have proposed an index – central fat distribution 
index (CDI) – calculated by subcutaneous abdominal fat 
area/total fat mass, obtained by Bioimpedance (Model 
BIA 101Q; RJL System;USA, ratio (cm2/kg) to evalu-
ate the impact of subcutaneous fat on central fat distri-
bution in hypertensive women. The study was approved 
by the Institutional Ethics Committee and written in-
formed consent was obtained from all participants.
Statistical analyses were performed using the com-
puter program SPSS 12.0. Data are shown as mean ± 
SD. The t-Student test was used to compare the two 
groups. Multiple linear regression analysis was used to 
assess the influence of VF, SCF and ISI on office-SBP 
(systolic blood pressure). Possible associations were as-
sessed through Pearson’s correlation coefficients. The 
level of significance was set at p < 0.05.
results
A total of 35 women were studied (NT-NO, n = 17 and 
HT-NO, n = 18). 72% of the hypertensive non-obese 
patients were postmenopausal women, while 41% of 
the normotensive non-obese patients were postmeno-
pausal women, but it was not a significant difference. 
Anthropometric measurements, fat areas and central fat 
distribution index are shown in table 1.
The hypertensive non-obese group showed greater 
visceral and subcutaneous fat areas than the normoten-
sive non-obese group (Figure 1).
When compared to the normotensive non-obese 
patients, the hypertensive non-obese patients had hi-
gher leptin levels (7.4 ± 3.5 versus 19.1 ± 9.6 ng/mL; 
p = 0.028), higher HOMAr index (0.93 ± 0.48 versus 
1.59 ± 0.72 mmol/L2; p = 0.006) and lower insulin 
sensitivity index (ISI) (1.08 ± 0.31 versus 0.82 ± 0.24; 
p = 0.012), as shown in table 2.
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was determinant of office-SBP (R2 = 0.106; p = 0.033; 
Backward).
DIscussIon 
Hyperinsulinemia has been considered the link between 
obesity, diabetes and arterial hypertension. As we know, 
obesity and diabetes mellitus are classical conditions of 
insulin resistance which has been attributed to higher 
visceral fat accumulation (2,16-18). Some studies have 
shown that arterial hypertension in the metabolic syn-
drome is associated to insulin resistance and central dis-
tribution of fat, increasing cardiovascular risk (3,5,9).
Of the hypertensive non-obese and normotensive 
non-obese patients, 71 and 41%, respectively, were post-
menopausal, but it was not a significant difference. Pre-
vious studies have demonstrated that postmenopausal 
status may predispose abdominal fat deposition (17,19) 
which may be considered a confounder factor in our 
sample. In fact, the higher central fat deposition found in 
the hypertensive non-obese women, compared to nor-
motensive non-obese women was associated to higher 
frequency of patients in the postmenopausal period. 
These results are in accordance with previous reported 
data indicating that greater central fat deposition is one 
the most important factors that determine higher insulin 
resistance and blood pressure levels. Those data are com-
patible with central fat distribution index that we have 
proposed, in which there are normotensive and hyper-
tensive patients, both non-obese, with increase of cen-
tral fat (increase of both subcutaneous and visceral fat). 
Thus, this index proposes that, not only visceral fat, but 
also subcutaneous abdominal fat may also have impact 
on insulin resistance and on hypertensive condition.
Van Harmelen and cols. showed that leptin is de-
rived mainly from subcutaneous tissue both in obese 
and non-obese women (11). In this study, higher leptin 
levels in non-obese hypertensive patients suggest that 
subcutaneous abdominal fat could produce more leptin 
than peripheral subcutaneous fat. In fact, a positive cor-
relation was found between subcutaneous abdominal 
fat and plasma leptin levels. This greater leptin produc-
tion, followed by increases in sympathetic nervous sys-
tem activity, could explain the higher insulin resistance 
and arterial blood pressure in non-obese women with 
central fat accumulation. Our results have differed from 
previous ones reported by Ferrannini and cols. (10) who 
found visceral fat but not subcutaneous fat accumula-
tion in hypertensive subjects. In our study, however, we 
table 1. Anthropometric characters, fat areas and central fat distribution index
 NT-NO (n = 17)  HT-NO (n = 18)
Age (years) 46.6 ± 9.1 52.6 ± 11.0
BMI (kg/m2) 23.0 ± 2.2 23.8 ± 2.3
Waist (cm) 71.3 ± 7.8 74.5 ± 9.9
Hip (cm) 89.6 ± 7.4 89.9 ± 7.9
WHR 0.80 ± 0.008 0.82 ± 0.06
VF-CT (cm2) 37.5 ± 23.0 84.4 ± 55.7*
SCF-CT (cm2) 79.8 ± 27.4 174.3 ± 83.0*
CDI (cm2/kg) 6.19 ± 2.57 12.67 ± 7.04*
* p < 0.05 versus NT-NO.
BMI: body mass index; WHR: waist-to-hip ratio; VF-CT: visceral fat area; SCF-CT: subcutaneous 
abdominal fat area; CDI: central fat distribution index. 
table 2. Metabolic parameters according to groups
 NT-NO (n = 17)  HT-NO (n = 18)
Fasting plasma glucose (mmol/L) 4.55 ± 0.46 4.80 ± 0.33
2-hr plasma glucose (mmol/L) 5.13 ± 0.93 6.20 ± 1.52
Fasting insulin (pmol/L) 31.05 ± 15.06 53.55 ± 22.45*
2-hr insulin (pmol/L) 249.17 ± 195.80 358.16 ± 181.42
HOMAr (mmol.mU/L2) 0.93 ± 0.48 1.59 ± 0.72*
HOMA β (%) 0.87 ± 0.82 1.20 ± 0.46
ISI index 1.08 ± 0.31 0.82 ± 0.24*
Leptin (ng/mL) 7.4 ± 3.5 19.1 ± 9.6*
*p < 0.05 versus NT-NO.
Figure 1. Visceral (VF) and subcutaneous abdominal (SCF) fat areas in groups.
We found inverse correlation between ISI and of-
fice systolic blood pressure values (r = -0.399; [-0.587; 
-0.170]; p = 0.001; CI 95%). Positive correlation was 
found between leptin and subcutaneous abdominal fat 
area (r = 0.462; [0.050; 0.740]; p = 0.030; CI 95%). 
Multiple linear regression analysis after adjustment 
for age and BMI, with office-SBP as the dependent 
variable, and visceral fat, subcutaneous abdominal fat 
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found greater subcutaneous abdominal and visceral fat 
deposition in hypertensive non-obese subjects.
conclusIon 
Arterial hypertension in non-obese women is associated 
with insulin resistance, central distribution of fat (visceral 
and subcutaneous abdominal) and higher leptin levels.
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